Drawing for PRISM RX CLEARLY DIFFERENT - A SPECTRUM OF SOLUTIONS

USPTO serial 76716985

PRISM RX CLEARLY DIFFERENT - A SPECTRUM OF SOLUTIONS

Reviewed by CopyMark Law Group

Status 606
Filing date
Status date
Registration date
—
Examiner
JUN, WON KYUNG WENDY
Law office
INTENT TO USE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with PRISM RX CLEARLY DIFFERENT - A SPECTRUM OF SOLUTIONS?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Kay Lyn Schwartz

Kay Lyn Schwartz GARDERE WYNNE & SEWELL LLP2021 McKinney Avenue, Suite 1600IP SECTIONDALLAS, TX 75201

Goods and services

ClassDescriptionStatusFirst use
035Pharmaceutical cost management services and drug utilization review services; Pharmacy management services, namely, prescription drug formulary management services; Pharmaceutical services, namely, processing online prescription orders in retail and central fill pharmacies; Supplying prescription drug services to health plan participants for the funding organizations; Business administration of pharmacy reimbursement programs and services; Mail order pharmacy services; Specialty pharmacy benefit management services with respect to high cost low incidence therapiesACTIVE—
036Pharmaceutical benefit management service, namely, insurance administration of prescription drug benefits; Reimbursement payment processing in the field of pharmaceutical claims; Insurance claims administration in the field of pharmaceutical claims; Design and development of pharmaceutical insurance benefit plans for othersACTIVE—
044Medical and pharmaceutical consultation, namely, pharmacist consultations services to health plan participants about pharmaceuticals for improvement of health outcomes; Medication therapy management services using technological advanced solutions; Health care services, namely, disease management programs using real time integrated data to make a positive impact on disease burdensACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (MAB6): The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.

DateCodeEventWhat it means
Jul 23, 2018MAB6ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Jul 23, 2018ABN6ABANDONMENT - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Feb 28, 2018ASCKASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY—
Nov 28, 2017EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Nov 27, 2017EX5GSOU EXTENSION 5 GRANTED—
Nov 21, 2017EXT5SOU EXTENSION 5 FILED—
Nov 21, 2017EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
May 20, 2017EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
May 18, 2017EX4GSOU EXTENSION 4 GRANTED—
May 18, 2017EXT4SOU EXTENSION 4 FILED—
May 18, 2017EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jan 20, 2017TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Dec 16, 2016EXRANOTICE OF APPROVAL OF EXTENSION REQUEST MAILED—
Dec 14, 2016EX3GSOU EXTENSION 3 GRANTED—
Dec 14, 2016EXT3SOU EXTENSION 3 FILED—
Dec 14, 2016EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jul 23, 2016EXRANOTICE OF APPROVAL OF EXTENSION REQUEST MAILED—
Jul 22, 2016EX2GSOU EXTENSION 2 GRANTED—
Jul 20, 2016AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
Jun 14, 2016EXT2SOU EXTENSION 2 FILED—
Jun 14, 2016EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Dec 17, 2015EXRANOTICE OF APPROVAL OF EXTENSION REQUEST MAILED—
Dec 15, 2015EX1GSOU EXTENSION 1 GRANTED—
Dec 15, 2015EXT1SOU EXTENSION 1 FILED—
Dec 15, 2015EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jun 16, 2015NOAMNOA MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Apr 21, 2015PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Apr 1, 2015NPUBNOTICE OF PUBLICATION—
Mar 16, 2015PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Mar 9, 2015CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Mar 9, 2015ACECAMENDMENT FROM APPLICANT ENTERED—
Mar 9, 2015CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Mar 6, 2015ALIEASSIGNED TO LIE—
Feb 27, 2015MAILPAPER RECEIVED—
Jan 26, 2015CNRTNON-FINAL ACTION MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jan 23, 2015CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jan 22, 2015DOCKASSIGNED TO EXAMINER—
Oct 14, 2014MAFRAPPLICATION FILING RECEIPT MAILED—
Oct 8, 2014NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—

Frequently asked questions

Related guidance